Be sure to discuss the risks and benefits of prolonged PPI therapy with your healthcare provider for optimal safety. H2 ...

The most widely used H. pylori treatments are 1-week triple therapy regimens involving twice daily dosing with a PPI, clarithromycin 500 mg and either amoxicillin 1 g or metronidazole 400−500 mg.

Currently, coxib therapy is more expensive than combination therapy using a nonselective NSAID plus a PPI. Conclusions: Compared with combination therapy including a nonselective NSAID and PPI ...

Use the lowest dose of Protonix and for the shortest duration of PPI therapy appropriate to the condition. PPI therapy may be associated with a greater risk of osteoporosis-related fractures of ...

The authors conclude that gastric acid suppression induced by PPIs, but not by H 2 RAs, is associated with an increased risk of salmonella and campylobacter enteric infections. They suggest that ...

pylori were randomly assigned to receive bacterial eradication with triple therapy for two weeks before or after four weeks ...

As acupuncture has shown considerable benefits in patients with various gastrointestinal disorders, Dickman and colleagues compared this alternative therapy with doubling the dose of the PPI in ...

A live webcast of the fireside chat can be accessed from the Investor Relations section of Inozyme’s website under events, where a replay of the event will also be available for a limited time.